6 | LigandsIBA
03/2017
-
01/2002 |
6 | delta Opioid Receptors (delta Opioid Receptor)IBA
07/2012
-
12/2002 |
5 | Opioid Receptors (Opioid Receptor)IBA
01/2017
-
06/2006 |
5 | Peptides (Polypeptides)IBA
06/2015
-
11/2002 |
5 | 2',6'- dimethyltyrosyl- 1,2,3,4- tetrahydroisoquinoline- 3- carboxylic acidIBA
08/2010
-
12/2002 |
5 | Opioid Analgesics (Opioids)IBA
03/2010
-
10/2005 |
4 | Biological ProductsIBA
03/2017
-
09/2010 |
4 | NociceptinIBA
01/2017
-
09/2002 |
4 | Proteins (Proteins, Gene)FDA Link
02/2014
-
11/2002 |
3 | Pharmaceutical PreparationsIBA
03/2017
-
01/2012 |
2 | NeuropeptidesIBA
11/2016
-
10/2005 |
2 | Amyloid beta-PeptidesIBA
10/2015
-
11/2002 |
2 | CytokinesIBA
06/2015
-
01/2015 |
2 | ChemokinesIBA
01/2015
-
08/2009 |
2 | Oxygen (Dioxygen)IBA
07/2013
-
09/2008 |
2 | Naltrexone (ReVia)FDA LinkGeneric
01/2012
-
08/2009 |
2 | Morphine (MS Contin)FDA LinkGeneric
01/2012
-
08/2009 |
2 | Freund's AdjuvantIBA
04/2011
-
08/2009 |
2 | Glucose (Dextrose)FDA LinkGeneric
08/2009
-
09/2008 |
2 | Opioid Peptides (Opioid Peptide)IBA
01/2004
-
01/2002 |
2 | AcidsIBA
12/2002
-
01/2002 |
1 | Celecoxib (Celebrex)FDA Link
01/2018 |
1 | Carbonic Anhydrases (Carbonic Anhydrase)IBA
01/2018 |
1 | Protein Isoforms (Isoforms)IBA
01/2018 |
1 | Nootropic Agents (Nootropics)IBA
03/2017 |
1 | Analgesics (Analgesic Drugs)IBA
03/2017 |
1 | Anti-Anxiety Agents (Anxiolytics)IBA
03/2017 |
1 | 6'- fluoro- 4',9'- dihydro- N,N- dimethyl- 4- phenylspiro(cyclohexane- 1,1'(3'H)- pyrano(3,4- b)indol)- 4- amineIBA
01/2017 |
1 | CannabinoidsIBA
11/2016 |
1 | CB1 Cannabinoid Receptor (CB1 Receptor)IBA
11/2016 |
1 | Hemoglobins (Hemoglobin)IBA
11/2016 |
1 | hemopressinIBA
11/2016 |
1 | Interleukin-10 (Interleukin 10)IBA
06/2015 |
1 | InterferonsIBA
06/2015 |
1 | InterleukinsIBA
06/2015 |
1 | Cytochromes c (Cytochrome c)IBA
06/2014 |
1 | StaurosporineIBA
06/2014 |
1 | Thymidylate SynthaseIBA
02/2014 |
1 | Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA
02/2014 |
1 | Brain-Derived Neurotrophic Factor (BDNF)IBA
07/2013 |
1 | 2',6'- dimethyltyrosyl- 1,2,3,4- tetrahydroisoquinoline- 3- carboxylic acid (1H- benzimidazol- 2- yl)(carboxymethyl)methylamideIBA
07/2013 |
1 | MicroRNAs (MicroRNA)IBA
01/2013 |
1 | Opiate AlkaloidsIBA
01/2012 |
1 | Naloxone (Narcan)FDA LinkGeneric
01/2012 |
1 | Biomarkers (Surrogate Marker)IBA
04/2011 |
1 | Antiviral Agents (Antivirals)IBA
09/2010 |
1 | Trypan BlueFDA Link
09/2010 |
1 | 2- tyrosyl- 1,2,3,4- tetrahydroisoquinoline- 3- carboxylic acidIBA
08/2010 |
1 | 1,2,3,4-tetrahydroisoquinolineIBA
03/2010 |
1 | Guanosine 5'-O-(3-Thiotriphosphate)IBA
03/2010 |
1 | GlycogenIBA
08/2009 |
1 | Insulin (Novolin)FDA Link
08/2009 |
1 | MineralsIBA
08/2009 |
1 | CholesterolIBA
08/2009 |
1 | 1,2,3,4- tetrahydroisoquinoline- 3- carboxylic acidIBA
01/2009 |
1 | Phenylalanine (L-Phenylalanine)FDA Link
01/2009 |
1 | 4- amino- 1,2,4,5- tetrahydro- 2- benzazepin- 3- oneIBA
01/2009 |
1 | benzimidazoleIBA
06/2006 |
1 | Haloperidol (Haldol)FDA LinkGeneric
10/2005 |
1 | Oxidopamine (6 Hydroxydopamine)IBA
10/2005 |
1 | hydroxide ionIBA
08/2005 |
1 | AminesIBA
08/2005 |
1 | AmidesIBA
08/2005 |
1 | Lysine (L-Lysine)FDA Link
08/2005 |
1 | 2',6'- dimethyltyrosyl- 1,2,3,4- tetrahydroisoquinolinecarbonyl- phenylalanyl- (N(epsilon)- benzyloxycarbonyl)lysineIBA
08/2005 |
1 | mu Opioid Receptors (mu Opioid Receptor)IBA
07/2004 |